{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-106395","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2026-10-02T20:16:12+00:00","discovered_at":"2026-10-02T20:17:00.266666+00:00","generated_at":"2026-10-12T14:37:15.685295+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Adial Pharmaceuticals adjourns 2026 annual meeting again over pending Nasdaq listing approval","bullets":["Adial adjourned votes on Proposals 3, 4, 5 and 6 at its 2026 Annual Meeting because Nasdaq had not approved its Initial Listing Application.","The reconvened Oct. 1, 2026 meeting was further adjourned; polls remain open and the meeting will reconvene Oct. 15, 2026 at 8:30 a.m. ET.","The record date for the 2026 Annual Meeting remains Aug. 17, 2026, and stockholders who already voted on Proposals 3-6 need not act unless changing their vote.","Proposals 1, 2, 7, 8, 9, 10, 11 and 12 were voted on at the Sept. 17, 2026 meeting; the definitive proxy statement was filed Aug. 24, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-106395","json":"https://secwatch.observer/filing/0001213900-26-106395.json","markdown":"https://secwatch.observer/filing/0001213900-26-106395.md","text":"https://secwatch.observer/filing/0001213900-26-106395.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026106395/0001213900-26-106395-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026106395/ea0307576-8k_adial.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:37:15.685295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}